Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lonza sets new goal to make Moderna COVID-19 vaccine ingredients
Moderna, which enlisted Lonza in May in a 10-year manufacturing contract, is racing with 100-plus other vaccine projects, having…
Reasonable to expect some coronavirus vaccine by year-end: US Army vaccine researcher
US Defense Secretary Mark Esper vowed on May 15 that the US military and other parts of the government would, in collaboration…
Nurses: A barrier between patients and counterfeit drugs
With an increase in pharma companies, number and types of drugs for patients, we must accept the growing role of nurses in patient…
Seven success stories of LSSSDC’s partnerships to fight COVID-19
Zydus Cadila, Cadila Pharma, Biocon, Syngene, Glenmark, Serum Institute of India, Ipca, Strides are using LSSSDC’s programmes to…
NPPA issues draft guidelines to tackle cases of discontinuation of scheduled formulations
Invites the industry stakeholders comments, suggestions before June 15, 2020
IIT, BHU to re-purpose approved drugs from DrugBank database for treating COVID-19
The research group is working on developing new drug candidates against SARS-CoV-2 by exploring DrugBank database compounds as an…
Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19
Kits to be launched under the brand name ELISafe 19
Office of PSA, DST initiate consultation process for new Science, Technology, and Innovation Policy
It will reorient the way research is done, and technologies are developed and deployed for larger socio-economic welfare, informs…
Industry appreciate revised MSME definition, recommend for more measures
The revised definition of MSME will be effective from July 1, 2020
Lupin receives US FDA approval for Meloxicam capsules
Lupin's Meloxicam capsules are a generic equivalent of Vivlodex Capsules of Zyla Life Sciences US